Losartan was the first nonpeptide AT 1 receptor antagonist approved by the Food and Drug Administration (1995) . After losartan, a large number of AT 1 receptor antagonists was introduced into the market: valsartan, irbesartan, eprosartan, candesartan, telmisartan, olmesartan, azilsartan and fimasartan (Je et The theoretical chemistry methods were used to elucidate absorption, distribution and physicochemical properties of AT 1 receptor antagonists and dual angiotensin II and endothelin A receptor antagonist (PS-433540). Computed partition coefficients (ALOGPS method) studied for drugs varied between 2.98 and 6.66. Neutral compounds are described as lipophilic drugs.
Telmisartan is a drug with the highest lipophilicity. The neutral forms of the studied AT 1 receptor antagonists are practically insoluble in water, and their computed solubilities is in interval between 2.04 and 22.65 mg/l (ALOGpS method). The calculated pK a values for tetrazolyle moiety are in the range 3.92-5.00 and for carboxylic moiety 3.12-5.50. Telmisartan (polar surface area = 72.95 Å) and irbesartan (polar surface area = 87.14 Å) belong to the AT 1 receptor antagonists with increased absorption.
Pre objasnenie absorpcie, distribúcie a fyzikálnochemických vlastností antagonistov AT 1 (Iwai et al., 2007) . In this paper, the results of theoretical calculations were used for the study of the lipophilicity, solubility, pK a , polar surface area (PSA) and selected absorption, distribution, metabolism and excretion (ADME) properties of both clinically useful and experimental AT 1 receptor antagonists (Murugesan et al., 2005) . The results of theoretical studies of these drugs were compared with the available experimental data and discussed in the relation to the present theories of these agents' activity. 
EXPERIMENTAL

Material and methods
RESULTS AND DISCUSSION
Lipophilicity and solubility
The computed and experimental log P values (P is the partition coefficient of the molecule in the 1-octanol/water system) are shown in Table 1 ). The experimental log P values of AT 1 receptor antagonists are preferably reproduced by the ALOGPs, so this method was used for further calculations. Log S, an intrinsic solubility in the neutral state, is an indication of compounds' solubility (S). The log S values were calculated using ALOGPS predictor. This method uses E-state indices as the descriptors and a neural network (Tetko et al., 2001b) as the modelling 'engine' . The computed solubilities of studied drugs were compared with the available experimental data (European Pharmacopoeia, Council of Europe, Strasbourg, 2014) and are shown in Table 2 . Drug solubility is one of the important factors that affect the drug movement from a point of administration into the blood site. It is very significant to know the drug solubility and that the insufficient solubility of drugs can lead to poor absorption (Zhao et al., 2002) . The investigation of the rate-limited steps of human oral absorption of 238 drugs (including warfarin) showed (Zhao et al., 2002 ) that the absorption of a drug is usually very low if the calculated solubility is <0.0001 mg/l.
The neutral forms of the studied AT 1 receptor antagonists are practically insoluble in water; their computed solubilities are in interval between 2.04 and 22.65 mg/l (ALOGpS). Increased solubility of valsartan (22.65 mg/l) can be caused by error of computational algorithm. The anion forms of the studied AT 1 receptor antagonists are practically insoluble in water; their computed solubilities are in interval between 3.22 and 89.41 mg/l (ALOGpS). In the clinical praxis, the AT 1 receptor antagonists are used as the salts forms, such as eprosartan mesylate, losartan potassium and fimasartan as potassium trihydrate. Losartan potassium is freely soluble in water. Fimasartan as potassium trihydrate is very slightly soluble in water.
Dissociation constants
The AT 1 receptor antagonists contain acidic carboxyl, tetrazolyl, 4,5-dihydro-1,2,4-oxadiazol-5-one (azilsartan) (Tosco et al., 2008) . b (Inglot et al., 2008 and sulphonamide (PS-433540) group, and thus they may undergo deprotonation reactions (Fig. 2) . However, dissociation constant in solution, that is, the pK a , is a measure of the strength of an acid or a base. Therefore, this parameter is very useful for understanding the behaviour of drug molecules at the site of action. Dissociation plays an important role in both partition and receptor binding processes of the drug action. Accordingly, it is important to know whether the drug molecules exist predominantly in the neutral or ionised forms. The Jaguar program was used for the prediction of the AT 1 receptor antagonists' pK a value in condensed phase (water).
The calculated pK a values are presented in Table 3 . Theoretical computed values of the pK a were compared with available experimental data (Cagigal et al., 2001; Tosco et al., 2008) . The presence of two acidic groups in some AT 1 receptor antagonists reduces gastrointestinal absorption and bioavailability. Two acidic groups are present in the structure of valsartan, eprosartan, candesartan, olmesartan and azilsartan. In the drug form, they are used as prodrugs, noneffective precursors that have favourable pharmacokinetic properties. This was achieved by esterification of the carboxylic acid by alcohols. The ester bond is easily hydrolysed into the active form after the absorption of the drug into the body. In clinical practice, candesartan (candesartan cilexetil), olmesartan (olmesartan medoxomil) and azilsartan (azilsartan 
Figure 2d. The dissociation pathways of the PS-433540. (Figure shows only selected drugs, other drugs make analogous deprotonation reactions).
medoxomil) are used as prodrugs. Then the active form binds to the active site of the AT 1 receptor. AT 1 receptor antagonists also contain a basic nitrogen group in their structure, namely, imidazole (losartan, EXP-3174, eprosartan, olmesartan), benzimidazole (candesartan, telmisartan, azilsartan), pyrimidine (fimasartan), diazaspiro[4.4]non-1-ene (irbesartan, PS-433540), isoxazole (PS-433540) or tertiary amino group (valsartan, fimasartan). Basic nitrogen atom is not significantly ionised at physiological pH of 7.4 in these functional groups ( Table 4) . The computed pK a values for tetrazolyl acidic group of the AT 1 receptor antagonists are in the range 3.92-5.00 (for calculated value, the root-mean-square deviation is 0.7). The calculated pK a values for the carboxylic acid are in the range 3.12-5.50 (for calculated value, the root-mean-square deviation is 0.4). At physiological pH of 7.4, these two acidic groups are ionised at a high rate (98.76-99.99; Table 3 ) and drugs will exist as dianions. These values are in relatively good agreement with experimental data ( (Hilal et al., 1995) . The pK a value of this group is pK a = 6.80. The Jaguar program does not include parameterisation for 4,5-dihydro-1,2,4-oxadiazol-5-one group. Theoretical pK a values of olmesartan computed by Jaguar indicate that C-terminal carboxyl group is more acidic (pK a = 3.72) than N-terminal tetrazolyl group (pK a = 4.82). This order of acidity explains why in prodrug of olmesartan, C-terminal carboxyl group is shielded with medoxomil group. Theoretical pK a values of candesartan computed by Jaguar indicate that C-terminal carboxyl group is more acidic (pK a = 3.82) than N-terminal tetrazolyl group (pK a = 3.92). This result is in a good agreement with experimental pK a values of candesartan (Table 3 ). This order of acidity explains why in prodrug of candesartan C-terminal carboxyl group, there is shielded with cilexetil group.
Polar surface area and "rules of five properties"
The high oral bioavailability is an important factor for the development of bioactive molecules as therapeutic agents. Passive intestinal absorption, reduced molecular flexibility (measured by the number of rotatable bonds), low PSA or (Muegge, 2003) . Lipinski (Lipinski et al., 1997 ) used these molecular properties in formulating his 'Rule of Five' . The rule states that most molecules with good membrane permeability have log P <5, molecular weight <500, a number of hydrogen bond acceptors <10 and a number of hydrogen bond donors <5. This rule is widely used as a filter for drug-like properties. Table 5 (Table 5) . Candesartan, olmesartan and azilsartan contain two ionisable acidic functional groups (tetrazolyl ring or 4,5-dihydro-1,2,4-oxadiazol-5-one and carboxyl group), and in physiological conditions, they are present in the form of charged species. Ionisation of acidic groups and high PSA of these drugs is not compatible with their oral application. Therefore, their prodrug forms were prepared: candesartan cilexetil, olmesartan medoxomil and azilsartan medoxomil. Although the forms of these prodrugs violate the Rule of Five (molecular mass 558.60-610.67 g/mol), they are metabolised to active forms in vivo, which are biologically active. Valsartan also contains two ionisable acidic groups, but lower value of the PSA compensates this deficiency, in comparison to candesartan, olmesartan and azilsartan. The calculated percentage of absorption does not correlate with the available experimental percentage of absolute absorption ( 
ADME properties
The pharmacokinetic ADME parameters of the AT 1 receptor antagonists were calculated using the QikProp program. All descriptors and pharmaceutically relevant properties were analysed, and significant descriptors are discussed in the following. These properties were 1. Predicted apparent Caco-2 cell permeability in nanometre per second (QPPCaco). Blood-brain barrier (BBB) permeability is a crucial factor that needs careful examination in the process of drug discovery. Drugs targeted in the CNS must cross BBB to exhibit therapeutic effect, whereas for non-CNS drugs, passage through the BBB may lead to unwanted side effects. The degree of BBB penetration is defined as the ratio of the steady-state concentrations of the drug in the brain and in the blood: BB = C brain /C blood . C is the concentration of the compound. BB of the most prescribed CNS drugs is >0.3 (log BB > −0.5), drugs with BB <0.1 (log BB < −1) penetrate poorly into the brain (Abraham et al., 1997) . Log BB was calculated using the Clark equation: log BB = −0.0148 PSA + 0.152 clogP + 0.139 (Clark, 1999) . ALOGPs values were selected for clogP (calculated logP). The AT 1 receptor antagonists can be considered as moderately well absorbed drugs (Caco-2 cell permeability is 5.26-633.07 nm/s, predicted human oral absorption is 55.42-100.00%). These values of AT 1 receptor antagonists are different because of the special structure of each drug. After analysis of the computed log BB values of the studied drugs showed that telmisartan penetrates through BBB easily and irbesartan penetrates through BBB with difficulty. All the other drugs with log BB close to −1 penetrates poorly into the brain (Table 6 ). Valsartan would probably not cross BB, which is inconsistent with the experimental data (Wang et al. 2007 ). This inconsistency can be caused by an active transport mechanism through BBB (Pardridge, 2012 
CONCLUSIONS
This theoretical study was set out to determine lipophilicity, solubility, gas-phase acidity, pK a and ADME properties of 10 antagonists of angiotensin AT 1 the range 3.20-5.50. At physiological pH of 7.4, these two acidic groups ionised at a high rate (98.76-99.99) and drugs exist as dianions. The pK a value of the 4,5-dihydro-1,2,4-oxadiazol-5-one moiety of azilsartan is 6.80 which is ionised at physiological pH partially (78,79). PS-433540 contains a sulphonamide acid group with pK a = 6.22, that is, at pH = 7.4 largely ionised (93.80%). IV. PS-433540 has higher molecular weight (592.76) and higher log P (5.56). The telmisartan violation of the Rule of Five (too high log P and molecular weight) is compensated by the low number of rotatable bonds (7) and lower PSA (72.95 Å). Lower absorption of candesartan, olmesartan and azilsartan (PSA = 118.83-129.82 Å) was improved by preparing their prodrug forms with improved oral bioavailability. The absorption and distribution parameters of the AT 1 receptor antagonists were calculated by QikProp. The AT 1 receptor antagonists can be considered as moderately well absorbed drugs. 
